We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Screening after invasive pneumococcal disease can uncover previously undiagnosed blood cancer and immune deficiency. More...
01 Oct 2026
Image Credit: 123RF

Genomic Classifier Predicts Benefit From Adding Hormone Therapy to Salvage Prostate Radiation

New data show a tumor test identifies prostate cancers more likely to benefit from hormone therapy with salvage radiotherapy. More...
01 Oct 2026
Image:Geographic distribution of the survey respondents. (Cavalier E, Kapoula G, Bhattoa HP, et al. IOF-IFCC international survey of global laboratory practices for bone status indices. Clin Chem Lab Med. 2026. DOI:10.1515/cclm-2026-0941.)

Global Survey Underscores Need to Standardize Bone Biomarker Testing

New data show variation across labs in bone marker testing, calling for harmonized reporting to improve clinical interpretation. More...
01 Oct 2026
Image: Developed and manufactured by Freenome and exclusively commercialized by Abbott, SimpleScreen CRC joins the Cologuard Plus test in Abbott’s screening portfolio, which now spans both stool‑ and blood‑based options (Photo courtesy of Freenome)

Blood-Based Test Broadens Colorectal Cancer Screening Options

An FDA-approved blood-based test detects colorectal cancer with 81% sensitivity and 90% specificity More...
01 Oct 2026
Image Credit: 123RF

Screening After Pneumococcal Infection May Reveal Undiagnosed Blood Cancer or Immune Disorders

Screening after invasive pneumococcal disease can uncover previously undiagnosed blood cancer and immune deficiency. More...
01 Oct 2026
Image Credit: 123RF

Screening After Pneumococcal Infection May Reveal Undiagnosed Blood Cancer or Immune Disorders

Screening after invasive pneumococcal disease can uncover previously undiagnosed blood cancer and immune deficiency. More...
01 Oct 2026
Image: (a) CTC separation using contraction-expansion inertial microfluidics. (b) CTC detection using the YOLOv8 deep learning model. (Image Credit: Junyi Ouyang, Haiqin Li)

Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis

A label-free platform combines microfluidic cell sorting with AI to enrich and identify rare circulating tumor cells. More...
01 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Automated Immunoassay Analyzer
SuperFlex™
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Copyright © 2000-2026 Globetech Media. All rights reserved.